Literature DB >> 11010831

Mechanisms of action of intravesical bacille Calmette-Guérin: local immune mechanisms.

S Prescott1, A M Jackson, S J Hawkyard, A B Alexandroff, K James.   

Abstract

The local immune response to mycobacteria is complex, but mycobacterial antigen presentation by phagocytes to T helper cells is the pivotal interaction. Bacille Calmette-Guérin (BCG) vaccination is associated with the development of antituberculosis immunity but not necessarily with antitumor immunity. Animal studies have shown that an intact host immune system is required for the antitumor activity of BCG. Immunosuppressed and, particularly, T cell-depleted individuals fail to respond to BCG immunotherapy. Clinical and laboratory evidence suggest that the antitumor activity is concentrated at the site of BCG administration, which reinforces the view that local immune mechanisms are responsible for this phenomenon.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11010831     DOI: 10.1086/314066

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  26 in total

Review 1.  Immunotherapy for Urothelial Carcinoma: Current Evidence and Future Directions.

Authors:  Abhishek Tripathi; Elizabeth R Plimack
Journal:  Curr Urol Rep       Date:  2018-11-07       Impact factor: 3.092

2.  Attenuated but live: a pelvic abscess caused by bacille Calmette-Guerin.

Authors:  Jerome A Leis; Daniel R Ricciuto; Wayne L Gold
Journal:  CMAJ       Date:  2011-06-13       Impact factor: 8.262

3.  A case of Pott's disease with epidural abscess and probable cerebral tuberculoma following Bacillus Calmette-Guérin therapy for superficial bladder cancer.

Authors:  Colin B Josephson; Saleh Al-Azri; Daniel J Smyth; David Haase; B Lynn Johnston
Journal:  Can J Infect Dis Med Microbiol       Date:  2010       Impact factor: 2.471

4.  The regulatory effects of polyporus polysaccharide on the nuclear factor kappa B signal pathway of bladder cancer cells stimulated by Bacillus Calmette-Guerin.

Authors:  Jian-An Wei; Xing Zeng; Ling Han; Yu Huang
Journal:  Chin J Integr Med       Date:  2011-07-03       Impact factor: 1.978

5.  Expression of Mycobacterium leprae HSP65 in tobacco and its effectiveness as an oral treatment in adjuvant-induced arthritis.

Authors:  César Rodríguez-Narciso; Mayra Pérez-Tapia; Rosa María Rangel-Cano; Celio L Silva; Mariana Meckes-Fisher; Rafael Salgado-Garciglia; Sergio Estrada-Parra; Rodolfo López-Gómez; Iris Estrada-García
Journal:  Transgenic Res       Date:  2010-06-06       Impact factor: 2.788

Review 6.  Checkpoint inhibitors: the new treatment paradigm for urothelial bladder cancer.

Authors:  Heather Katz; Emnet Wassie; Mohamed Alsharedi
Journal:  Med Oncol       Date:  2017-09-01       Impact factor: 3.064

7.  Subclinical miliary Mycobacterium bovis following BCG immunotherapy for transitional cell carcinoma of the bladder.

Authors:  Chang-Ho Ryan Choi; Sang Oh Lee; Geoff Smith
Journal:  BMJ Case Rep       Date:  2014-05-08

8.  Bacillus Calmette Guerin induces fibroblast activation both directly and through macrophages in a mouse bladder cancer model.

Authors:  Catalina Lodillinsky; Yanina Langle; Ariel Guionet; Adrián Góngora; Alberto Baldi; Eduardo O Sandes; Alberto Casabé; Ana María Eiján
Journal:  PLoS One       Date:  2010-10-22       Impact factor: 3.240

9.  The Tumor Microenvironment of Bladder Cancer.

Authors:  Ken Hatogai; Randy F Sweis
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

10.  Acute renal failure due to interstitial nephritis after intravesical instillation of BCG.

Authors:  Maria Jose Manzanera Escribano; Enrique Morales Ruiz; Mónica Odriozola Grijalba; Eduardo Gutierrez Martínez; Alfredo Rodriguez Antolín; Manuel Praga Terente
Journal:  Clin Exp Nephrol       Date:  2007-09-28       Impact factor: 2.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.